New England Journal of Medicine Catalyst study shows company backed by Independence Blue Cross helps save members nearly $1,000 per year on a generic drug BenefitsPress Releases New England Journal of Medicine Catalyst study shows company backed by Independence Blue Cross helps save members nearly $1,000 per year on a generic drug A unique approach to improving access to lower-cost generic medications has led to an average…Independence Blue Cross NewsroomMay 22, 2025
Independence Blue Cross partnering with Civica to increase access to affordable insulin BCBSA NewsCompany UpdatesHealth & Well-beingInnovationPress Releases Independence Blue Cross partnering with Civica to increase access to affordable insulin Civica to manufacture and distribute three insulins for $30 or less per vial Today, Independence…Independence Blue Cross NewsroomMar 3, 2022